Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. - Wikidata - wikimedia - TriplyDB

Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients.

Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients.

http://www.wikidata.org/entity/Q40675352

about

Clindamycin as an antimalarial drug: review of clinical trials.Multiple dose study of interactions between artesunate and artemisinin in healthy volunteers Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial Pregnane X receptor and natural products: beyond drug-drug interactions Combinations of artemisinin and quinine for uncomplicated falciparum malaria: efficacy and pharmacodynamics.Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.Artemisinin drugs: novel antimalarial agents.Artemisinin pharmacokinetics and efficacy in uncomplicated-malaria patients treated with two different dosage regimens Artemisinin‐induced dormancy in plasmodium falciparum: duration, recovery rates, and implications in treatment failure.Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon.Antimalarial drug resistance and combination chemotherapy.Artemisinins.A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria.Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malaria.A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-pass hepatic extraction.Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin.Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy.Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study.Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study.Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria.The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam.Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia.Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.Access to artemisinin combination therapy for malaria in remote areas of Cambodia.Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children.Artemisinin production in Artemisia annua: studies in planta and results of a novel delivery method for treating malaria and other neglected diseases.Population pharmacokinetic properties of artemisinin in healthy male Vietnamese volunteers.Effect of food intake on pharmacokinetics of oral artemisinin in healthy Vietnamese subjects.Malaria treatment using novel nano-based drug delivery systems.Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria.Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone Characterisation of the human liver in vitro metabolic pattern of artemisinin and auto-induction in the rat by use of nonlinear mixed effects modelling.Therapeutic equivalence of a low dose artemisinin formulation in falciparum malaria patients.Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer.More insights into the pharmacological effects of artemisinin.Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects.Pharmacokinetics and pharmacodynamics of arterolane maleate following multiple oral doses in adult patients with P. falciparum malaria.Artemisinin-Based Combination Therapy Depressed Mitosis and Induced Chromosome Aberration in Onion Root Cells

P2860

Q24536057-A54C8BA1-C735-4098-9ACF-ACBB7D4CD0EA Q28362543-E3FF43F9-4E52-4FFB-9557-A14FC0BD127E Q28542921-B7A09349-35B0-4231-AE3B-A965F5BD3486 Q28748504-BBD177EB-CB1D-4779-850B-6CA6092C8E21 Q33979461-ADF049E7-DFC7-430C-90E3-CF6BA0B96E3B Q33982362-629AA1A8-D114-43DB-B6B0-E223B3992875 Q34075018-59470072-95C2-4F57-BE0A-9B3B9960FC67 Q34105652-7728180E-6F81-48D6-9371-E4504DD9FE8C Q34172447-BAC47437-7093-4123-AC18-0CDC089C95DB Q34734703-7FF2CA4A-7DD7-4E7B-BFBF-52E3208866E5 Q35212414-6B6C7DD1-0373-4648-9793-F884A639257C Q35521094-D89D9766-ADE5-45D5-A565-ED036998814E Q35802096-B785D9FD-2428-42FB-B71F-8A117F48D778 Q35803021-8E3CA608-FE4D-43A2-8411-9BD429F13233 Q35826682-3E469BDE-192E-40A9-8192-484C0575144D Q35827084-3BB1C110-D58A-4095-A202-53365088B86A Q35860086-0D53738C-DAEA-4254-A24D-482C837E9D7F Q35941440-90369221-4B02-4FB5-B852-A8CE629DEB36 Q35941455-279B4ED9-F516-4979-8B00-6A3786048A2E Q36018642-29C013EE-72AA-4A37-92D6-9494E314AFE4 Q36138872-A7989A34-7D68-4E7F-B77E-27624F6C5F5B Q36364184-ACE91C7F-0300-426C-A715-576B8D740936 Q36669256-DB416B6B-5D94-4EE9-B8A2-11EED832F972 Q36726339-56D3019D-38C7-422C-846F-E499E5C9BCA2 Q37517983-4E4D4EF5-0582-44DA-9677-21E008356556 Q37885184-7EEF3153-C34D-4C90-A5F2-0BBB51CCBC5B Q38487882-8A6E286F-115A-4F65-AA67-9B16D3E19F1A Q38973078-165E5386-00A1-49D0-B66A-B633FD118121 Q39122575-3A4D618D-0F67-4F9B-B499-A0DFB13082AE Q39132767-74F05CC8-9042-4E18-9B81-E5185CCEBB6A Q40914424-DD3ED1F9-D39E-4F4F-BB97-AFE053D24887 Q42445249-6F3B234A-1C54-4432-98A8-3586F080A203 Q44347372-863A9DD4-4915-4E4F-9E5A-D7F61D06C26C Q44358811-BCC9A76D-C0AF-4EBA-A2B1-3EF92C768B95 Q44872854-4DEC4EAC-C612-49E9-A1F1-1E74EA5ABACE Q46250415-FD73E8CF-2D42-4046-AD00-1667CDAFF369 Q47833388-FF6156C7-CEEA-48F0-896F-1298886B41FE Q47967717-6BFC764A-4765-4885-A8C4-ECB370C01ACC Q58711572-24FC88D3-E99A-495A-88B1-9E8910379D71

P2860

Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients.

http://www.wikidata.org/entity/Q40675352

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Multiple dose pharmacokinetics ...... n falciparum malaria patients.

@en

type

label

Multiple dose pharmacokinetics ...... n falciparum malaria patients.

@en

prefLabel

Multiple dose pharmacokinetics ...... n falciparum malaria patients.

@en

P1433

Q40675352-40926A01-770D-4851-B01B-E6AB776AD9DB

P1476

Q40675352-CDB60D2E-9D5D-40BD-97EC-60E1FB21AE48

P2093

Q40675352-3FA28CFF-55A6-465F-8E5C-BA4BDF111598

Q40675352-5E23D114-D7A8-4F86-8082-00D4E4D29AB1

Q40675352-6877491F-E1C8-46B7-B145-83DDC8AD14B2

Q40675352-98692087-DE44-49CD-A78E-19FA139D5C35

Q40675352-CFE09DF8-D294-421B-8DCA-68D983051CDD

P2860

Q40675352-452079B7-7169-43CE-9B6B-EB4C8F09F3FD

Q40675352-A607F0C0-7F02-4613-AA6C-7D463F44AAA9

Q40675352-A64CB677-B7A7-4B56-9457-4A24B3711307

Q40675352-FCFE7A17-76F6-4EA7-8150-D64F499A80D5

P304

Q40675352-435E5D86-3F98-4C00-9581-63DC08C2C9E8

P31

Q40675352-F635C862-C46B-4AF9-BA40-41339870DC0B

P356

Q40675352-1142E0EB-BC7D-4283-B1C7-A79AD04F3BF7

P433

Q40675352-8DEB548E-E67B-45A7-A2F6-28B927027FE7

P478

Q40675352-97829C3A-D4C4-4040-B95C-FE8B207DA76A

P577

Q40675352-8DCF44E0-A96C-459C-8A82-BBCD65F98268

P698

Q40675352-D2A2909B-4C40-4373-A9B2-EB8DBBDCE7FD

P921

Q40675352-0A8097E6-5A0D-4DA6-9414-F1DD33088734

Q40675352-0F3AB7B7-441E-4A69-BA27-19FAC7DFF349

Q40675352-7116647C-D754-4CB7-9762-4140A7F6DCB5

Q40675352-D4F20B98-3A82-4EC6-BA6A-754D2127F5C7

P356

S0035-9203(96)90480-0

P1433

Transactions of the Royal Society of Tropical Medicine and Hygiene

P1476

Multiple dose pharmacokinetics ...... n falciparum malaria patients.

@en

P2093

Ashton M

http://www.w3.org/2001/XMLSchema#string

Björkman A

http://www.w3.org/2001/XMLSchema#string

Hassan Alin M

http://www.w3.org/2001/XMLSchema#string

Kihamia CM

http://www.w3.org/2001/XMLSchema#string

Mtey GJ

http://www.w3.org/2001/XMLSchema#string

P2860

Alpha 1-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria

Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria.

The effect of artemisinine, its derivatives and mefloquine against chloroquine-resistant strains of Plasmodium falciparum in vitro.

In vitro activity of artemisinin, its derivatives, and pyronaridine against different strains of Plasmodium falciparum.

P304

61-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0035-9203(96)90480-0

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

1996-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8730315

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum